Apeiron RIA’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,934
Closed -$256K 222
2025
Q2
$256K Sell
2,934
-380
-11% -$32.2K 0.07% 182
2025
Q1
$298K Sell
3,314
-410
-11% -$36.7K 0.09% 160
2024
Q4
$297K Buy
3,724
+1,084
+41% +$93.8K 0.08% 165
2024
Q3
$238K Sell
2,640
-1
-0% -$84 0.07% 187
2024
Q2
$208K Sell
2,641
-189
-7% -$15.5K 0.06% 198
2024
Q1
$247K Buy
2,830
+147
+5% +$12.5K 0.07% 185
2023
Q4
$221K Sell
2,683
-412
-13% -$31.4K 0.07% 186
2023
Q3
$243K Buy
3,095
+289
+10% +$24.2K 0.08% 172
2023
Q2
$247K Buy
2,806
+253
+10% +$21.8K 0.08% 171
2023
Q1
$206K Buy
+2,553
New +$208K 0.07% 186

Other funds holding MDT

Apeiron RIA's MDT Position: Q3 2025 in Review

Apeiron RIA sold out of Medtronic (MDT) in Q3 2025, closing a stake of 2,934 shares — an estimated $256K sold.

Apeiron RIA first reported a position in MDT in Q1 2023 and held it in 10 quarters. The position peaked at $298K in Q1 2025. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Apeiron RIA reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Apeiron RIA sold 2,934 Medtronic shares in Q3 2025, an estimated $256K.
  • Apeiron RIA first reported a position in Medtronic in Q1 2023 and held it in 10 quarters.
  • Apeiron RIA's Medtronic position peaked at $298K in Q1 2025.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Apeiron RIA's 13F filing for Q3 2025, filed 14 Oct 2025.